BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1324088)

  • 21. Absence of basal ganglia amino acid neuron deficits in schizophrenia in three collections of brains.
    Simpson MD; Slater P; Deakin JF; Gottfries CG; Karlsson I; Grenfeldt B; Crow TJ
    Schizophr Res; 1998 May; 31(2-3):167-75. PubMed ID: 9689721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of a highly efficient "binding" to bacterial contamination can distort data from binding studies.
    Balcar VJ
    Neurochem Res; 1990 Dec; 15(12):1237-8. PubMed ID: 1965858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of chronic tiagabine treatment on [3H]GABAA, [3H]GABAB and [3H]tiagabine binding to sections from mice brain.
    Thomsen C; Suzdak PD
    Epilepsy Res; 1995 Jun; 21(2):79-88. PubMed ID: 7588591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (3H)-muscimol, (3H)-nipecotic acid and (3H)-isoguvacine as autoradiographic markers for GABA neurotransmission.
    Agardh E; Ehinger B
    J Neural Transm; 1982; 54(1-2):1-18. PubMed ID: 6286870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of gamma-aminobutyric acid (GABA)-transaminase inhibitors and a GABA uptake inhibitor to investigate the influence of GABA neurons on dopamine-containing amacrine cells of the rat retina.
    Proll MA; Morgan WW
    J Pharmacol Exp Ther; 1983 Dec; 227(3):627-32. PubMed ID: 6140307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between (RS)-nipecotic acid and GABA transport in cultured astrocytes: coupling with two sodium ions.
    Larsson OM; Schousboe A
    Neurochem Res; 1981 Mar; 6(3):257-66. PubMed ID: 7279105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced GABA uptake sites in the temporal lobe in schizophrenia.
    Simpson MD; Slater P; Deakin JF; Royston MC; Skan WJ
    Neurosci Lett; 1989 Dec; 107(1-3):211-5. PubMed ID: 2616032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma-aminobutyric acid uptake and the termination of inhibitory synaptic potentials in the rat hippocampal slice.
    Dingledine R; Korn SJ
    J Physiol; 1985 Sep; 366():387-409. PubMed ID: 2414435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic characterization of inhibition of gamma-aminobutyric acid uptake into cultured neurons and astrocytes by 4,4-diphenyl-3-butenyl derivatives of nipecotic acid and guvacine.
    Larsson OM; Falch E; Krogsgaard-Larsen P; Schousboe A
    J Neurochem; 1988 Mar; 50(3):818-23. PubMed ID: 3339356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synaptic interactions in the GABA system during postnatal development in retina.
    Madtes PC; Redburn DA
    Brain Res Bull; 1983 Jun; 10(6):741-5. PubMed ID: 6311358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GABA agonists and uptake inhibitors. Synthesis, absolute stereochemistry, and enantioselectivity of (R)-(-)- and (S)-(+)-homo-beta-proline.
    Nielsen L; Brehm L; Krogsgaard-Larsen P
    J Med Chem; 1990 Jan; 33(1):71-7. PubMed ID: 2153214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple components of synaptosomal [3H]-gamma-aminobutyric acid release resolved by a rapid superfusion system.
    Turner TJ; Goldin SM
    Biochemistry; 1989 Jan; 28(2):586-93. PubMed ID: 2653424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-correlated decline in [3H]tiagabine binding to GAT-1 in human frontal cortex.
    Sundman-Eriksson I; Allard P
    Aging Clin Exp Res; 2006 Jun; 18(3):257-60. PubMed ID: 16804373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regionally selective deficits in uptake sites for glutamate and gamma-aminobutyric acid in the basal ganglia in schizophrenia.
    Simpson MD; Slater P; Royston MC; Deakin JF
    Psychiatry Res; 1992 Jun; 42(3):273-82. PubMed ID: 1353892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitors of the GABA uptake systems.
    Krogsgaard-Larsen P
    Mol Cell Biochem; 1980 Jun; 31(2):105-21. PubMed ID: 6251361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the mechanism of interactions between anesthetic steroids and gamma-aminobutyric acidA receptors.
    Im WB; Blakeman DP; Davis JP; Ayer DE
    Mol Pharmacol; 1990 Mar; 37(3):429-34. PubMed ID: 2156155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel GABAA antagonist [3H]SR 95531: microscopic analysis of binding in the rat brain and allosteric modulation by several benzodiazepine and barbiturate receptor ligands.
    McCabe RT; Wamsley JK; Yezuita JP; Olsen RW
    Synapse; 1988; 2(2):163-73. PubMed ID: 2844001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex-differences and stress: effects on regional high and low affinity [3H]GABA binding.
    Skilbeck KJ; Hinton T; Johnston GA
    Neurochem Int; 2008 May; 52(6):1212-9. PubMed ID: 18295376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia.
    Reynolds GP; Czudek C; Andrews HB
    Biol Psychiatry; 1990 May; 27(9):1038-44. PubMed ID: 2159350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action.
    Pilc A; Lloyd KG
    Life Sci; 1984 Nov; 35(21):2149-54. PubMed ID: 6092815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.